DK0755259T3 - Kimære-cDNA-kloner af virussen for den infektiöse GUMBORO-syge, ekspressionsprodukter heraf og vacciner baseret derpå - Google Patents

Kimære-cDNA-kloner af virussen for den infektiöse GUMBORO-syge, ekspressionsprodukter heraf og vacciner baseret derpå

Info

Publication number
DK0755259T3
DK0755259T3 DK95914198T DK95914198T DK0755259T3 DK 0755259 T3 DK0755259 T3 DK 0755259T3 DK 95914198 T DK95914198 T DK 95914198T DK 95914198 T DK95914198 T DK 95914198T DK 0755259 T3 DK0755259 T3 DK 0755259T3
Authority
DK
Denmark
Prior art keywords
ibdv
infectious
strains
virus
genetic
Prior art date
Application number
DK95914198T
Other languages
English (en)
Inventor
Vikram Vakharia
David B Snyder
Stephanie A Mengel-Whersat
Original Assignee
Univ Maryland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Maryland filed Critical Univ Maryland
Application granted granted Critical
Publication of DK0755259T3 publication Critical patent/DK0755259T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/10011—Birnaviridae
    • C12N2720/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK95914198T 1994-03-29 1995-03-29 Kimære-cDNA-kloner af virussen for den infektiöse GUMBORO-syge, ekspressionsprodukter heraf og vacciner baseret derpå DK0755259T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/219,262 US5788970A (en) 1994-03-29 1994-03-29 Chimeric infectious bursal disease virus CDNA clones, expression products and vaccines based thereon

Publications (1)

Publication Number Publication Date
DK0755259T3 true DK0755259T3 (da) 2005-11-28

Family

ID=22818561

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95914198T DK0755259T3 (da) 1994-03-29 1995-03-29 Kimære-cDNA-kloner af virussen for den infektiöse GUMBORO-syge, ekspressionsprodukter heraf og vacciner baseret derpå

Country Status (10)

Country Link
US (3) US5788970A (da)
EP (1) EP0755259B1 (da)
JP (2) JPH09510873A (da)
AT (1) ATE300950T1 (da)
AU (1) AU696656B2 (da)
CA (1) CA2186856A1 (da)
DE (1) DE69534354T2 (da)
DK (1) DK0755259T3 (da)
ES (1) ES2249769T3 (da)
WO (1) WO1995026196A1 (da)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5871744A (en) * 1996-09-05 1999-02-16 University Of Maryland-Biotechnology Inst. Method for generating birnavirus from synthetic RNA transcripts
EP0887412B1 (en) * 1997-05-26 2003-10-15 Akzo Nobel N.V. Recombinant birnavirus vaccine
CA2238659C (en) 1997-05-26 2010-12-14 Akzo Nobel N.V. Recombinant birnavirus vaccine
US6231868B1 (en) 1997-09-30 2001-05-15 University Of Maryland-Biotechnology Institute Method for generating nonpathogenic infections birnavirus from synthetic RNA transcripts
WO1999050419A2 (en) * 1998-03-31 1999-10-07 University Of Maryland Biotechnology Institute A method for generating nonpathogenic, infectious pancreatic necrosis virus (ipnv) from synthetic rna transcripts
WO2000012677A2 (en) * 1998-09-01 2000-03-09 The University Of Hong Kong Generation of recombinant infectious bursal disease viruses by reverse genetics technology and the use of the recombinant viruses as attenuated vaccines
US6492148B1 (en) * 1999-03-05 2002-12-10 Akzo Nobel Nv Genetically engineered cell culture adapted infectious bursal disease virus (IBDV) mutants
US6468984B1 (en) 1999-06-08 2002-10-22 Innovo Biotechnologies Ltd. DNA vaccine for protecting an avian against infectious bursal disease virus
EP1069187A1 (en) * 1999-07-14 2001-01-17 Stichting Dienst Landbouwkundig Onderzoek Mosaic Infectious Bursal Disease Virus vaccines
WO2001092486A1 (en) * 2000-05-31 2001-12-06 Akzo Nobel N.V. Serotype chimeric ibdv strains
EP1296710A4 (en) * 2000-06-19 2004-05-12 Rahan Meristem RECOMBINANT VACCINES AGAINST INFECTIOUS BURSITY VIRUS
EP1170302B1 (en) * 2000-07-07 2006-06-21 Intervet International BV Infectious bursal disease virus vaccines
US6485940B2 (en) 2000-07-07 2002-11-26 Akzo Nobel N.V. Broad spectrum infectious bursal disease virus vaccine
WO2002038753A1 (fr) * 2000-11-09 2002-05-16 Junichi Watanabe Procede de criblage d'un gene agissant sur les conditions pathologiques ou la survie d'un animal infecte par un pathogene
WO2003013597A1 (en) * 2001-08-10 2003-02-20 University Of Maryland Biotechnology Institute Sub-unit vaccine for infectious pancreatic necrosis virus
EP1483287A1 (en) * 2002-03-01 2004-12-08 Akzo Nobel N.V. An infectious bursal disease virus variant
US7431930B2 (en) 2002-03-01 2008-10-07 Intervet International B.V. Infectious bursal disease virus (IBDV) mutant expressing virus neutralising epitopes specific for classic-and variant IBDV strains
PL1908822T3 (pl) * 2003-03-24 2011-03-31 Intervet Int Bv Mutanty wirusa zakaźnego zapalenia torby Fabrycjusza i szczepionki
ES2217967B1 (es) * 2003-03-31 2006-01-01 Consejo Sup. Investig. Cientificas Procedimiento de produccion de particulas virales vacias (vlps) del virus inductor de la bursitis infecciosa (ibdv), composiciones necesarias para su puesta a punto y su uso en la elaboracion de vacunas frente al ibdv.
ES2307345B1 (es) * 2004-01-21 2009-11-13 Consejo Sup. Investig. Cientificas Capsidas vacias quimericas del virus causante de la enfermedad de la bursitis infecciosa (ibdv), su procedimiento de obtencion y aplicaciones.
ES2307346B1 (es) * 2004-01-21 2009-11-13 Consejo Sup. Investig. Cientificas Capsidas vacias (vlps(-vp4)) del virus causante de la enfermedad de la bursitis infecciosa (ibdv), su procedimiento de obtencion y aplicaciones.
EP2272949A3 (en) * 2004-03-12 2011-01-19 Wyeth LLC Infectious bursal disease virus antigenic isolates and vaccines
US7244432B2 (en) * 2004-12-08 2007-07-17 University Of Maryland Biotechnology Institute Infectious bursal disease virus (IBDV) variant from Georgia
US7491399B2 (en) 2005-06-23 2009-02-17 University Of Maryland Biotechnology Institute In Ovo vaccine against infectious bursal disease
ES2310062B1 (es) * 2005-07-15 2009-11-13 Bionostra, S.L. Particulas pseudovirales vacias quimericas derivadas del virus causante de la enfermedad de la bursitis infecciosa (ibdv), procedimiento de obtencion y aplicaciones.
WO2007020017A1 (en) * 2005-08-12 2007-02-22 Bionostra, S.L. Composition for bird immunization administered by aerosol
AU2007303608B2 (en) 2006-09-29 2013-05-02 Takeda Vaccines, Inc. Norovirus vaccine formulations
KR20100083150A (ko) 2007-09-18 2010-07-21 리고사이트 파머슈티컬즈 인코퍼레이티드 노로바이러스에 대한 보호면역반응을 제공하는 방법
US20100266636A1 (en) 2007-09-18 2010-10-21 Ligocyte Pharmaceuticals, Inc. Method of conferring a protective immune response to norovirus
EP2288618B1 (en) * 2008-05-09 2017-09-20 Chimera Pharma S.l.u. Chimeric fusion proteins and virus like particles from birnavirus vp2
AU2009279456B2 (en) * 2008-08-08 2015-02-05 Takeda Vaccines, Inc. Virus-like particles comprising composite capsid amino acid sequences for enhanced cross reactivity
EP2505640A1 (en) 2011-03-29 2012-10-03 Neo Virnatech, S.L. Vaccine compositions for birnavirus-borne diseases
EA035442B1 (ru) 2011-07-11 2020-06-17 Такеда Вэксинс, Инк. Композиции, содержащие буфер, вакцины, которые содержат композиции, содержащие буфер, и пути их применения
CN112159480B (zh) * 2020-10-15 2022-03-22 福建农林大学 一种鸡传染性法氏囊病病毒多抗原表位蛋白及其应用
CN112409454B (zh) * 2020-11-04 2022-07-05 青岛农业大学 一种法氏囊七肽及其制备方法和应用
CN112375125B (zh) * 2020-11-23 2021-09-28 东北农业大学 一种多肽及其在预防鸡传染性法氏囊病中的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4908305A (en) * 1987-06-14 1990-03-13 The University Of Maryland Competitive elisa for determination of neutralizing IBDV antibody
AU643216B2 (en) * 1989-05-30 1993-11-11 Commonwealth Scientific And Industrial Research Organisation Production of IBDV VP2 in highly immunogenic form
US5595912A (en) * 1990-05-04 1997-01-21 University Of Maryland College Park Specific DNA and RNA sequences associated with US IBDV variants, vector carrying DNA sequences, host carrying cloned vector, deduced amino acid sequences, vaccine and method of vaccination
AU7955591A (en) * 1990-05-04 1991-11-27 University Of Maryland At College Park, The Specific dna sequences related to an ibdv protein including vectors, hosts and vaccines

Also Published As

Publication number Publication date
EP0755259A4 (en) 1999-12-22
JP2005200420A (ja) 2005-07-28
US6017759A (en) 2000-01-25
ATE300950T1 (de) 2005-08-15
CA2186856A1 (en) 1995-10-05
JPH09510873A (ja) 1997-11-04
AU696656B2 (en) 1998-09-17
US5788970A (en) 1998-08-04
DE69534354D1 (de) 2005-09-08
ES2249769T3 (es) 2006-04-01
WO1995026196A1 (en) 1995-10-05
EP0755259B1 (en) 2005-08-03
EP0755259A1 (en) 1997-01-29
US6156314A (en) 2000-12-05
DE69534354T2 (de) 2006-03-23
AU2129195A (en) 1995-10-17

Similar Documents

Publication Publication Date Title
DK0755259T3 (da) Kimære-cDNA-kloner af virussen for den infektiöse GUMBORO-syge, ekspressionsprodukter heraf og vacciner baseret derpå
Zanetti et al. The immunology of new generation vaccines
DK0584348T3 (da) Genetisk vaccine mod immundefektvirusser
NO20002413D0 (no) Antistoffer mot Moraxella proteiner og anvendelse derav, samt sett for pÕvisning av antigen og farmasøytisk preparat som inneholder antistoffer
EP2425848A3 (en) Influenza immunogen and vaccine
PT91881A (pt) Processo para a preparacao de novas proteinas e peptideos de hiv uteis no diagnostico, profilaxia ou terapia da sida
Wang et al. Virus-like particles of hepatitis B virus core protein containing five mimotopes of infectious bursal disease virus (IBDV) protect chickens against IBDV
NZ232505A (en) Conjugate comprising hepatitis b core antigen (hbcag) particles coupled to a polypeptide with an antigenic epitope
Francis Peptide vaccines for viral diseases
Liew New aspects of vaccine development.
Arnon Peptides as immunogens: prospects for synthetic vaccines
US4946676A (en) Vaccine comprising an immunogenic protein and, as an adjuvant, a substantially non-immunogenic, sequentially homologous peptide
CY1105176T1 (el) Χιμαιρικα νουκλεϊνικα οξεα και πολυπεπτιδια του ιου της λυσσας
DE3064590D1 (en) Process for the preparation of influenza a virus vaccinating strains, vaccinating strain and vaccine containing it
MX2022007217A (es) Vacuna epitópica para virus de fiebre porcina africana.
Winton Molecular approaches to fish vaccines
DE69331459T2 (de) Parenterale immunisierung gegen rotavirus
Osterhaus et al. Modulation of the immune system towards antiviral immune response using anti-idiotypic structures
DE68926813T2 (de) Von gemeinsamen sequenzen von antigenen und antiidiotypischen antikörpern oder von antikörpern mit spezifizität für die zellulären rezeptoren der antigene abgeleitete immunogene und biologisch aktive peptide
Mir Chamsy et al. Attempts to vaccinate foals with living tissue culture adapted horse sickness virus
KR930012826A (ko) 변형된 소의 헤르페스바이러스 타입 1에 기초한 백신
Thanavala Anti-idiotype vaccines
RU2020125383A (ru) ПЕПТИДНЫЕ ИММУНОГЕНЫ И СОДЕРЖАЩИЕ ИХ СОСТАВЫ, НАЦЕЛЕННЫЕ НА МЕМБРАНОСВЯЗАННЫЕ IgE ДЛЯ ЛЕЧЕНИЯ ОПОСРЕДОВАННЫХ IgE АЛЛЕРГИЧЕСКИХ ЗАБОЛЕВАНИЙ
Brown Peptide vaccines
Corvaisier et al. Identification of T-cell epitopes adjacent to neutralizing antigenic domains on the fusion protein of respiratory syncytial virus